mTOR (p = 0.003) and p-mTOR (p = 0.02) staining was associated with stage of disease, with lower staining scores in the tumor center of advanced stage cancers (T3 and T4) compared to early disease (T1 and T2). This evidence concerns the gene MTOR and cancer.